Top compounds associated with response to POLE3


Feature Type Standardized
Nominal ANOVA
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.0012 1
mRNA Imatinib GDSC1000 pan-cancer AAC -0.00065 1
mRNA Cyclopamine FIMM pan-cancer AAC 0.001 1
mRNA staurosporine CTRPv2 pan-cancer AAC 0.00011 1
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 5.7e-05 1
mRNA ABT-263 FIMM pan-cancer AAC 6.6e-05 1
Download CSV